Perfil
Michael N.
Avallone has been Chief Financial Officer of AMAG Pharmaceuticals, Inc. since joining the company in July 2004 and Vice President of Finance since August 2004.
From 2000 to 2004, Mr. Avallone worked at Boston Biomedica, Inc., including as Corporate Controller and Vice President of Finance and Chief Financial Officer.
He held various executive positions in accounting and finance at affiliates of NSTAR.
Antiguos cargos conocidos de Michael N. Avallone.
| Empresas | Cargo | Fin |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Director Financiero/CFO | 21/03/2007 |
| PRESSURE BIOSCIENCES, INC. | Director Financiero/CFO | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PRESSURE BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael N. Avallone
